Catalano PM, Shankar K
Available from: Chen CY, Chiu CH, Wu IW, Hsu HJ, Chen YT, Hsu CK et al
Most patients experience minimal to no adverse effects
GLP-1Rs are expressed in the pancreas, intestinal intraepithelial lymphocytes, myocardium, adipose tissue, kidney, liver, blood vessels, lungs and in the CNS.2,3 Although GLP-1 is known for its incretin effect, which it shares with glucose-dependent insulinotropic peptide (GIP), the intake-regulating action, essential for its efficacy against obesity, occurs through its interaction with receptors located in the CNS.1,5 The GLP-1 peptide can reach the central nervous system (CNS) via peripheral vagal afferents, which transmit its action through the nodose ganglion to the nucleus tactus solitarius (NTS)
According to statistics, Hispanics are the fastest growing minority group in the United States, with a population exceeding 50 million.This particular community therefore, collectively, possesses purchasing power to the tune of hundreds of billions